US Patent 7052691 Methods of treating diabetes by blocking VEGF-mediated activity
Patent 7052691 was granted and assigned to Regeneron Pharmaceuticals on May, 2006 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 26, 2004
0
Date of Patent
May 30, 2006
0
Patent Application Number
10811170
0
Patent Inventor Names
Mark W. Sleeman
0
Stanley J. Wiegand
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7052691 Methods of treating diabetes by blocking VEGF-mediated activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
